Ken Griffin Icad Inc Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.19 - $1.74 $2,499 - $3,654	2,100 Added 140.0%	3,600 $5,000
Q2 2024 Aug 14, 2024	SELL	$1.28 - $1.9 $3,072 - $4,560	-2,400 Reduced 61.54%	1,500 $1,000
Q1 2024 May 15, 2024	BUY	$1.35 - $2.27 $4,455 - $7,491	3,300 Added 550.0%	3,900 $6,000
Q4 2023 Feb 14, 2024	SELL	$1.27 - $2.06 $18,796 - $30,488	-14,800 Reduced 96.1%	600 $1,000
Q3 2023 Nov 14, 2023	BUY	$1.8 - $3.61 $27,720 - $55,594	15,400 New	15,400 $32,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.84 $7,320 - $17,324	6,100 Added 1016.67%	6,700 $8,000
Q4 2022 Feb 14, 2023	BUY	$1.6 - $2.37 $960 - $1,422	600 New	600 $1,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $44.8M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.